Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Endocrinol Metab ; 311(1): E186-201, 2016 07 01.
Article in English | MEDLINE | ID: mdl-27221116

ABSTRACT

ß-Cell insulin secretion is dependent on proper mitochondrial function. Various studies have clearly shown that the Nr4a family of orphan nuclear receptors is essential for fuel utilization and mitochondrial function in liver, muscle, and adipose. Previously, we have demonstrated that overexpression of Nr4a1 or Nr4a3 is sufficient to induce proliferation of pancreatic ß-cells. In this study, we examined whether Nr4a expression impacts pancreatic ß-cell mitochondrial function. Here, we show that ß-cell mitochondrial respiration is dependent on the nuclear receptors Nr4a1 and Nr4a3. Mitochondrial respiration in permeabilized cells was significantly decreased in ß-cells lacking Nr4a1 or Nr4a3. Furthermore, respiration rates of intact cells deficient for Nr4a1 or Nr4a3 in the presence of 16 mM glucose resulted in decreased glucose mediated oxygen consumption. Consistent with this reduction in respiration, a significant decrease in glucose-stimulated insulin secretion rates is observed with deletion of Nr4a1 or Nr4a3. Interestingly, the changes in respiration and insulin secretion occur without a reduction in mitochondrial content, suggesting decreased mitochondrial function. We establish that knockdown of Nr4a1 and Nr4a3 results in decreased expression of the mitochondrial dehydrogenase subunits Idh3g and Sdhb. We demonstrate that loss of Nr4a1 and Nr4a3 impedes production of ATP and ultimately inhibits glucose-stimulated insulin secretion. These data demonstrate for the first time that the orphan nuclear receptors Nr4a1 and Nr4a3 are critical for ß-cell mitochondrial function and insulin secretion.


Subject(s)
Cell Respiration/genetics , DNA-Binding Proteins/genetics , Insulin-Secreting Cells/metabolism , Insulin/metabolism , Mitochondria/metabolism , Nerve Tissue Proteins/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , RNA, Messenger/metabolism , Adenosine Triphosphate/metabolism , Animals , Cell Line, Tumor , Cell Survival , Gene Knockdown Techniques , Glucose/metabolism , Immunoblotting , Insulin Secretion , Isocitrate Dehydrogenase/genetics , Isocitrate Dehydrogenase/metabolism , Rats , Real-Time Polymerase Chain Reaction , Succinate Dehydrogenase/genetics , Succinate Dehydrogenase/metabolism
2.
Nutr Res ; 34(4): 308-17, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24774067

ABSTRACT

Selenium (Se) has been implicated as a micronutrient that decreases adenosine monophosphate-activated protein kinase (AMPK) signaling and may increase diabetes risk by reducing insulin sensitivity. Soy isoflavones (IF) are estrogen-like compounds that have been shown to attenuate insulin resistance, hyperglycemia, adiposity, and increased AMPK activation. We hypothesized that a high IF (HIF) diet would prevent the poor metabolic profile associated with high Se intake. The purpose of this study was to examine changes in basal glucose metabolism and AMPK signaling in response to an HIF diet and/or supplemental Se in a mouse model. Male FVB mice were divided into groups receiving either a control diet with minimal IF (low IF) or an HIF diet. Each dietary group was further subdivided into groups receiving either water or Se at a dose of 3 mg Se/kg body weight daily, as Se-methylselenocysteine (SMSC). After 5 months, mice receiving SMSC had elevated fasting glucose (P < .05) and a tendency for glucose intolerance (P = .08). The increase in dietary IF did not result in improved fasting blood glucose. Interestingly, after 6 months, HIF-fed mice had decreased basal AMPK activation in liver and skeletal muscle tissue (P < .05). Basal glucose metabolism was changed by SMSC supplementation as evidenced by increased fasting blood glucose and glucose intolerance. High dietary IF levels did not protect against aberrant blood glucose. In FVB mice, decreased basal AMPK activation is not the mechanism through which Se exerts its effect. These results suggest that more research must be done to elucidate the role of Se and IF in glucose metabolism.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Blood Glucose/metabolism , Diet , Glucose Intolerance/etiology , Isoflavones/pharmacology , Selenium/adverse effects , Selenocysteine/analogs & derivatives , Animals , Dietary Supplements , Fasting , Insulin Resistance , Isoflavones/therapeutic use , Liver/drug effects , Male , Mice , Mice, Inbred Strains , Muscle, Skeletal/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Selenium/pharmacology , Selenocysteine/adverse effects , Selenocysteine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...